BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Humphries J, Pizzi D, Sonderegger SE, Fletcher NL, Houston ZH, Bell CA, Kempe K, Thurecht KJ. Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure–Activity Comparison of Biodistribution. Biomacromolecules 2020;21:3318-31. [DOI: 10.1021/acs.biomac.0c00765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mills JA, Humphries J, Simpson JD, Sonderegger SE, Thurecht KJ, Fletcher NL. Modulating Macrophage Clearance of Nanoparticles: Comparison of Small-Molecule and Biologic Drugs as Pharmacokinetic Modifiers of Soft Nanomaterials. Mol Pharm 2022. [PMID: 36069540 DOI: 10.1021/acs.molpharmaceut.2c00528] [Reference Citation Analysis]
2 Marei HE. Multimodal targeting of glioma with functionalized nanoparticles. Cancer Cell Int 2022;22:265. [PMID: 35999629 DOI: 10.1186/s12935-022-02687-8] [Reference Citation Analysis]
3 Mills JA, Liu F, Jarrett TR, Fletcher NL, Thurecht KJ. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomater Sci 2022. [PMID: 35419582 DOI: 10.1039/d2bm00181k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Janowicz PW, Houston ZH, Bunt J, Fletcher NL, Bell CA, Cowin G, Howard CB, Taslima D, Westra van Holthe N, Prior A, Soh V, Ghosh S, Humphries J, Huda P, Mahler SM, Richards LJ, Thurecht KJ. Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li L, Yan X, Xia M, Shen B, Cao Y, Wu X, Sun J, Zhang Y, Zhang M. Nanoparticle/Nanocarrier Formulation as an Antigen: The Immunogenicity and Antigenicity of Itself. Mol Pharm 2022;19:148-59. [PMID: 34886673 DOI: 10.1021/acs.molpharmaceut.1c00704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hahn L, Beudert M, Gutmann M, Keßler L, Stahlhut P, Fischer L, Karakaya E, Lorson T, Thievessen I, Detsch R, Lühmann T, Luxenhofer R. From Thermogelling Hydrogels toward Functional Bioinks: Controlled Modification and Cytocompatible Crosslinking. Macromol Biosci 2021;:e2100122. [PMID: 34292657 DOI: 10.1002/mabi.202100122] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Tieu T, Wei Y, Cifuentes‐rius A, Voelcker NH. Overcoming Barriers: Clinical Translation of siRNA Nanomedicines. Adv Therap 2021;4:2100108. [DOI: 10.1002/adtp.202100108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ediriweera GR, Chen L, Yerbury JJ, Thurecht KJ, Vine KL. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives. Mol Pharm 2021;18:2142-60. [PMID: 34010004 DOI: 10.1021/acs.molpharmaceut.1c00297] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Leiske MN, Lai M, Amarasena T, Davis TP, Thurecht KJ, Kent SJ, Kempe K. Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood. Biomaterials 2021;274:120843. [PMID: 33984635 DOI: 10.1016/j.biomaterials.2021.120843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pizzi D, Mahmoud AM, Klein T, Morrow JP, Humphries J, Houston ZH, Fletcher NL, Bell CA, Thurecht KJ, Kempe K. Poly(2-ethyl-2-oxazoline) bottlebrushes: How nanomaterial dimensions can influence biological interactions. European Polymer Journal 2021;151:110447. [DOI: 10.1016/j.eurpolymj.2021.110447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sun F, Chou Y, Huang Q, Hu J, Ting Y. Making Concentrated Pterostilbene Highly Bioavailable in Pressure Processed Phospholipid Nanoemulsion. Processes 2021;9:294. [DOI: 10.3390/pr9020294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Deepagan VG, Leiske MN, Fletcher NL, Rudd D, Tieu T, Kirkwood N, Thurecht KJ, Kempe K, Voelcker NH, Cifuentes-Rius A. Engineering Fluorescent Gold Nanoclusters Using Xanthate-Functionalized Hydrophilic Polymers: Toward Enhanced Monodispersity and Stability. Nano Lett 2021;21:476-84. [PMID: 33350838 DOI: 10.1021/acs.nanolett.0c03930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
13 Marasini N, Fu C, Fletcher NL, Subasic C, Er G, Mardon K, Thurecht KJ, Whittaker AK, Kaminskas LM. The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats. Nanomaterials (Basel) 2020;10:E2452. [PMID: 33302413 DOI: 10.3390/nano10122452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]